Stryker Introduces its “SmartRobotics™ Stadium” to Indianapolis Indians Fans as Part of 10-City Tour of Minor League Ballparks

Today, Stryker continues its run with Minor League Baseball™ (MiLB™), stopping at Victory Field to bring the SmartRobotics™ Stadium booth to Indianapolis Indians fans. On Thursday, July 15 and Friday, July 16, Stryker will join fans at the ballpark to showcase the latest innovation in joint replacement technology, Mako SmartRobotics™.

Stryker will have a local orthopaedic surgeon on-site to speak with individuals about joint health and treatment options that may have been put off during the pandemic. Additionally, fans are encouraged to participate in engaging and entertaining activities in between innings at the booth.

“Whether you are looking for a fun night with the family or a new place to go with friends, Victory Field is a great place to catch the Indians play,” said Don Payerle, president of Stryker’s Joint Replacement division. “We invite the fans to visit our SmartRobotics™ Stadium booth to learn more about the importance of joint health so they can continue to jump to their feet and cheer for their team.”

Those in attendance will also learn more about Stryker during the games through videoboard commercials and promotions, including a seat upgrade for a lucky fan and a seventh-inning stretch promotion. In addition to the game day events, local orthopaedic surgeons will be back at Victory Field on Thursday, August 19, to host an educational seminar teaching fans about joint health and the latest treatment options, including Mako SmartRobotics™ robotic-arm assisted surgery and other nonsurgical options.

Lastly, as part of its “Own the Walk” charitable program, Stryker will donate $1 to K9s For Warriors – the nation’s largest provider of service dogs to American veterans living with military-related trauma – for every walk issued to a batter during the regular season. Stryker has been a committed partner of K9s For Warriors since 2015, having sponsored 31 service dogs to date — the largest number by any corporate partner.

It’s Time to Get Patients Back in the Game

At the start of the pandemic, many individuals and their physicians decided to delay necessary orthopaedic procedures, with some facilities having to stop them entirely until the pandemic was better controlled. However, putting off surgery could result in increased use of medications, a more difficult recovery and even more complicated surgeries, according to a recent Lancet study.[1] Now, it is time to ensure that healthcare professionals start to talk to patients again about revisiting their treatment options.

To register for the seminar on August 19 and learn more about joint health treatment options, please visit

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.